BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2430264)

  • 1. Antinociceptive and Met-enkephalin releasing effects of tachykinins and substance P fragments.
    Naranjo JR; Arnedo A; De Felipe MC; Del Rio J
    Peptides; 1986; 7(3):419-23. PubMed ID: 2430264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P-induced release of Met5-enkephalin from striatal and periaqueductal gray slices.
    Del Río J; Naranjo JR; Yang HY; Costa E
    Brain Res; 1983 Nov; 279(1-2):121-6. PubMed ID: 6196090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural effects of tachykinins and related peptides.
    Elliott PJ; Iversen SD
    Brain Res; 1986 Aug; 381(1):68-76. PubMed ID: 2428433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locomotor activation induced in rodent by substance P and analogues. Blockade of the effect of substance P by met-enkephalin antiserum.
    Naranjo JR; Del Rio J
    Neuropharmacology; 1984 Oct; 23(10):1167-71. PubMed ID: 6084200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of substance P and neurokinin A (substance K) on motor behavior: unique effect of substance P attributable to its amino-terminal sequence.
    Hall ME; Grantham P; Limoli J; Stewart JM
    Brain Res; 1987 Sep; 420(1):82-94. PubMed ID: 2445433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: activating opioid receptors through amygdala-periaqueductal gray pathway.
    Xu W; Lundeberg T; Wang YT; Li Y; Yu LC
    Neuroscience; 2003; 118(4):1015-22. PubMed ID: 12732246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal release of Met-enkephalin and neurotensin in the ventrolateral periaqueductal gray matter of the rat: a microdialysis study of antinociceptive circuits.
    Williams FG; Mullet MA; Beitz AJ
    Brain Res; 1995 Sep; 690(2):207-16. PubMed ID: 8535838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse effects of tachykinins on luteinizing hormone release in male rats: mechanism of action.
    Kalra PS; Sahu A; Bonavera JJ; Kalra SP
    Endocrinology; 1992 Sep; 131(3):1195-201. PubMed ID: 1380435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lasting neurochemical and functional changes in rats induced by neonatal administration of substance P antiserum.
    De Felipe MC; Molinero MT; Del Río J
    Brain Res; 1989 Apr; 485(2):301-8. PubMed ID: 2470472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tachykinin receptor subtype. Central cardiovascular regulation of tachykinin peptides.
    Takano Y; Nagashima A; Hagio T; Nakayama Y; Kamiya H
    Ann N Y Acad Sci; 1991; 632():476-8. PubMed ID: 1719908
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of tachykinins with an adrenergic receptor in the rat urinary bladder.
    Mathison R; Solomos D
    Eur J Pharmacol; 1985 Mar; 109(3):327-33. PubMed ID: 2580719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurones in vitro.
    Chieng B; Christie MJ
    Br J Pharmacol; 1994 Sep; 113(1):121-8. PubMed ID: 7812601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Place aversion induced by microinjections of C-fragment of substance P into the dorsal periaqueductal gray of rats is mediated by tachykinin NK1 receptors.
    De Araújo JE; Huston JP; Brandão ML
    Peptides; 2001 Sep; 22(9):1447-52. PubMed ID: 11514027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor.
    Figini M; Emanueli C; Bertrand C; Javdan P; Geppetti P
    Br J Pharmacol; 1996 Mar; 117(6):1270-6. PubMed ID: 8882625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid peptides (DAGO-enkephalin, dynorphin A(1-13), BAM 22P) microinjected into the rat brainstem: comparison of their antinociceptive effect and their effect on neuronal firing in the rostral ventromedial medulla.
    Fang FG; Haws CM; Drasner K; Williamson A; Fields HL
    Brain Res; 1989 Oct; 501(1):116-28. PubMed ID: 2572306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance P microinjected into the periaqueductal gray matter induces antinociception and is released following morphine administration.
    Rosén A; Zhang YX; Lund I; Lundeberg T; Yu LC
    Brain Res; 2004 Mar; 1001(1-2):87-94. PubMed ID: 14972657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance P release in the rat periaqueductal gray and preoptic anterior hypothalamus after noxious cold stimulation: effect of selective mu and kappa opioid agonists.
    Xin L; Geller EB; Liu-Chen LY; Chen C; Adler MW
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1055-63. PubMed ID: 9262375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution of substance P and met-enkephalin in the periaqueductal gray matter of the rat.
    Gioia M; Bianchi R
    Basic Appl Histochem; 1988; 32(1):103-8. PubMed ID: 2455501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural effects of intrathecally injected tachykinins in rats with peripheral nerve transection.
    Kuwahara H; Sakurada T; Sakurada S; Yonezawa A; Ando R; Kisara K; Osakada F; Munekata E
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):656-60. PubMed ID: 2451137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray.
    De Araújo JE; Huston JP; Brandão ML
    Eur J Pharmacol; 2001 Nov; 432(1):43-51. PubMed ID: 11734186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.